Figure 3From: A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapyObserved rate of a rectosigmoid mucosal change (RMC) score ≥3 (a) and late rectal complication (LRC) grade ≥2 (b) according to the dose-volumetric parameters. Abbreviations: same as in Table2 and Figure1. *p < 0.05, Fisher’s exact test.Back to article page